Browsing Tag
Medicare Advantage
20 posts
Why Sagility’s CareSeed acquisition could sharpen its AI-led healthcare analytics story
Sagility is buying CareSeed to move deeper into United States healthcare analytics. The test is whether the deal improves growth quality. Read more.
MedeAnalytics expands enterprise analytics as health plans face Medicare Advantage and employer cost squeeze
Medicare Advantage pressure is rising. See why MedeAnalytics is turning payer analytics into a performance-control contest.
How the NOPAIN Act could support broader reimbursement momentum for EXPAREL
Could the NOPAIN Act accelerate EXPAREL adoption in outpatient orthopedic surgery? Explore the reimbursement and opioid-reduction implications.
Lifeward (Nasdaq: LFWD) bets on oral insulin platform to escape medical device treadmill
Lifeward (LFWD) posts full-year 2025 revenue of $22M, down 14%, as shareholders approve the Oramed POD platform deal. Here is what it means for LFWD investors. Read more.
CVS stock slips as Aetna settles Medicare Advantage diagnosis code fraud case for $117.7m
CVS Health's Aetna to pay $117.7M over Medicare Advantage diagnosis code fraud. Read what this means for CVS stock and managed care enforcement.
Humana deepens senior care strategy as CenterWell absorbs MaxHealth primary care platform
CenterWell has acquired MaxHealth to expand Humana Inc.’s value-based primary care reach in Florida. Find out what this means for Medicare Advantage and healthcare consolidation.
Can UnitedHealth bounce back after CMS’s reimbursement shock blindsides investors?
UnitedHealth’s stock plunge after CMS’s Medicare rate proposal has rattled markets. Find out what triggered the selloff and what’s next for UNH.
Firstsource (NSE: FSL) acquires TeleMedik to scale clinical AI services across U.S. health plans
Firstsource acquires TeleMedik to expand AI-powered clinical services for U.S. payers. Find out how this move reshapes healthcare outsourcing strategy.
Medicare Advantage faces first enrollment decline in a decade—are UnitedHealth and Humana ready?
Medicare Advantage enrollment may fall by nearly 1 million in 2026. Find out why this shift matters for insurers, investors, and seniors.
Centene stock jumps 12% after reaffirming guidance: Will Medicaid and Medicare optimism sustain the rally?
Centene Corporation (NYSE: CNC) surged over 12% intraday on September 11, 2025, after management reaffirmed its full-year earnings guidance and revealed unexpectedly strong Medicare Advantage quality scores and Medicaid enrollment trends. This confidence boost set off a sector-wide rally among managed care peers, as investor sentiment rebounded sharply from months of policy-driven anxiety.